$HZNP Horizon Therapeutics Public Ltd Co Insider Trading Week 12/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Horizon Therapeutics Public Ltd Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Horizon Therapeutics Public Ltd Co in week 12/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | M | 0.00 | 19,250 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | M | 0.00 | 19,250 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 26.84 | 8,528 | 228,892 | 118,579 | 127.1 K to 118.6 K (-6.71 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 26.84 | 8,528 | 228,892 | 118,579 | 127.1 K to 118.6 K (-6.71 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Buy | M | 0.00 | 19,250 | 0 | 127,107 | 107.9 K to 127.1 K (+17.85 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Buy | M | 0.00 | 19,250 | 0 | 127,107 | 107.9 K to 127.1 K (+17.85 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 125,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 125,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 26.84 | 55,375 | 1,486,265 | 844,246 | 899.6 K to 844.2 K (-6.16 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 26.84 | 55,375 | 1,486,265 | 844,246 | 899.6 K to 844.2 K (-6.16 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 125,000 | 0 | 899,621 | 774.6 K to 899.6 K (+16.14 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 125,000 | 0 | 899,621 | 774.6 K to 899.6 K (+16.14 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 104,431 | 108.6 K to 104.4 K (-3.87 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 104,431 | 108.6 K to 104.4 K (-3.87 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 9,500 | 0 | 108,640 | 99.1 K to 108.6 K (+9.58 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 9,500 | 0 | 108,640 | 99.1 K to 108.6 K (+9.58 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Option Exercise | M | 0.00 | 6,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Option Exercise | M | 0.00 | 6,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Payment of Exercise | F | 26.84 | 2,880 | 77,299 | 105,580 | 108.5 K to 105.6 K (-2.66 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Payment of Exercise | F | 26.84 | 2,880 | 77,299 | 105,580 | 108.5 K to 105.6 K (-2.66 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Buy | M | 0.00 | 6,500 | 0 | 108,460 | 102 K to 108.5 K (+6.38 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Buy | M | 0.00 | 6,500 | 0 | 108,460 | 102 K to 108.5 K (+6.38 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 68,154 | 72.4 K to 68.2 K (-5.82 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 68,154 | 72.4 K to 68.2 K (-5.82 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 9,500 | 0 | 72,363 | 62.9 K to 72.4 K (+15.11 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 9,500 | 0 | 72,363 | 62.9 K to 72.4 K (+15.11 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 199,626 | 213.4 K to 199.6 K (-6.44 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 199,626 | 213.4 K to 199.6 K (-6.44 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 31,000 | 0 | 213,359 | 182.4 K to 213.4 K (+17.00 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 31,000 | 0 | 213,359 | 182.4 K to 213.4 K (+17.00 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 17,267 | 31 K to 17.3 K (-44.30 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 17,267 | 31 K to 17.3 K (-44.30 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 31,000 | 0 to 31 K |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 31,000 | 0 to 31 K |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 104,707 | 108.9 K to 104.7 K (-3.86 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 104,707 | 108.9 K to 104.7 K (-3.86 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 9,500 | 0 | 108,916 | 99.4 K to 108.9 K (+9.56 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 9,500 | 0 | 108,916 | 99.4 K to 108.9 K (+9.56 %) |